touchHEMATOLOGY

Trusted by professionals shaping the future of MedEd The strongest endorsement comes from the people we work with. At the heart of everything we do is collaboration, trust, and creating impactful medical education that supports healthcare professionals worldwide. We’re proud to share feedback from Erik Aerts on their experience working with us, and why trusted partnerships remain central to our success. Hear their perspective and discover why so many choose to work with us. Join the community today. Register now: touchhaematology.com/your-free-10-m… #MedicalEducation #HealthcareLeadership #Partnership #HealthcareCommunity #TrustedVoices

🚨 We’re now on TikTok 🚨 Touch Medical Media has officially launched on TikTok. Follow us for fresh, engaging content created for healthcare professionals from clinically relevant insights and key medical updates to behind-the-scenes moments. Expect: 👀 Bite-sized expert insights 🎥 Behind-the-scenes content 🩺 Thought-provoking healthcare stories ⚡ Fast, relevant updates Be among the first to follow us and join the journey. 📲 Follow us here: @touchmedicalmedia" target="_blank" rel="nofollow noopener">tiktok.com/@touchmedicalm… #TouchMedicalMedia #TikTok #HealthcareContent #MedicalEducation #HCP #DigitalHealth #MedComms

Revisited... 📊 Optimizing outcomes in CP-CML: In this CME-accredited panel, CML experts discuss real-world experience using approved TKIs, including monitoring responses and managing side effects. Gain practical, guideline-informed insights for clinical practice. Watch here: touchhaematologyime.org/cp-cml-tki-str…

🌟 touchHEMATOLOGY Future Leaders 2026 We want to hear from you! ✨ What qualities do you think make a great Future Leader in hematology? Tell us in the comments below ⬇️ Don’t miss your chance to recognise a rising star shaping the future of hematology. ✨ Place your nomination today: touchhaematology.com/insight/nomina… 📄Full nomination criteria is available through the link above. #FutureLeaders2026 #Haematology #Hematology #RisingStars #NextGenLeaders #MedicalEducation

📢 Don’t forget to nominate your touchHEMATOLOGY Future Leaders 2026! Is there a rising star you think should be on our 2026 list? ✨ Make your nomination today: touchhaematology.com/insight/nomina… 📄Revisit our 2025 list: touchhaematology.com/insight/touchh… #FutureLeaders2026 #Haematology #Hematology #RisingStars #NextGenLeaders #MedicalEducation

Have you seen our latest #YouTube video? ‘Advancing outcomes in CP-CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management’ Watch now: youtu.be/Yxt_Vw6uKuw #Hematology #CML #Leukemia #TKIs #HCPeducation #MedicalEducation

📢 In case you missed it - EBMT 2026 highlights We recently shared key insights from the 52nd Annual Meeting of the EBMT (EBMT 2026), in proud collaboration with EBMT. The meeting showcased rapid progress in transplant and cellular therapies, with expert perspectives from Dr Anna Sureda (EBMT President) and Dr Rafael Duarte (Congress President) on innovation, collaboration and translating research into clinical practice. Coverage included major developments in CAR-T monitoring using AI, gene therapy in primary immunodeficiencies, and new therapeutic options for refractory viral infections. Catch up on the highlights here: touchhaematology.com/insight/ebmt-2… @theebmt #EBMT2026 #Hematology #Transplantation #CellularTherapy #CART #GeneTherapy

🌟 Exciting news! 🌟 🎙️ Our podcast series Visionary Voices is now on Spotify! 🎙️ Join us and our incredible guests as we explore key trends, innovations and the stories shaping the pharmaceutical and healthcare industries. 🎧 Ready to tune in? Click below to explore our episodes! 👉 Listen now on Spotify: open.spotify.com/show/6RG0gKHFj… #Podcast #VisionaryVoices #HealthcareInnovation #TouchMedicalMedia

Are you making the most of your voice as a clinician? In partnership with LEADderm, we’re launching a mini-series from the LEADderm 2025 Congress, focused on career growth, wellbeing and leadership. 🎙️ In this episode, Dr Jennifer Soung and journalist Denise Mann discuss how clinicians can build meaningful media relationships to educate and empower at scale. 💡 You’ll learn: • Why media engagement matters • How to build confidence • Practical steps to get started 👉 Listen now and expand your impact beyond the clinic: touchhaematology.com/podcast/buildi… #HealthcareLeadership #MedicalEducation #ClinicalLeadership #HealthcareCommunication #ProfessionalDevelopment

Nominations for touchHEMATOLOGY Future Leaders 2026 are now open! “As we make incredible progress in the treatments of various haematological conditions, and our patients are living longer and better, it is a great time to encourage the young physician researchers and scientists to join the field and build on the progress so far, and enable a cure for many of these diseases. Programs such as this will provide the incentive for the young upcoming leaders to showcase themselves." - Dr Shaji Kumar, Mayo Clinic Who do you think is shaping the future of the field? ✨ Make your nomination today: touchhaematology.com/insight/nomina… 📄Full nomination criteria is available through the link above. #FutureLeaders2026 #Haematology #Hematology #RisingStars #NextGenLeaders #MedicalEducation

💡 Unlock the latest in Haematology research! Stay up-to-date with the newest insights, clinical advancements, and expert opinions in blood disorders and treatments. Subscribe to the touchHAEMATOLOGY platform today and be the first to know! 🌟 Get exclusive access to research summaries, treatment updates, and more—all tailored for healthcare professionals. 📬 Register now: touchhaematology.com/your-free-10-m… #Haematology #BloodHealth #MedicalNews

📢 Acute lymphoblastic leukaemia: Immunotherapy impact across the age spectrum In this Haematology Horizons practice pearl, Dr Hannah Levavi, Haematologist at Icahn School of Medicine at Mount Sinai, explores how CAR-T therapy is transforming care for patients with Acute Lymphoblastic Leukaemia, particularly older or transplant-ineligible individuals. Key insights include: 🔹 The growing role of immunotherapy earlier in the disease course 🔹 Reduced reliance on intensive chemotherapy for some patients 🔹 Emerging innovations such as allogeneic cell therapies and new antigen targets Read more: touchhaematology.com/insight/pp-che… #Haematology #Leukaemia #Immunotherapy

📢 EBMT 2026: Highlights from the 52nd Annual Meeting In proud collaboration with EBMT, we bring you key highlights from the 52nd Annual Meeting (EBMT 2026), showcasing the latest advances in transplant and cellular therapies. Hear from leading voices including Dr Anna Sureda (EBMT President) and Dr Rafael Duarte (Congress President) on the power of collaboration, innovation and rapid progress across the field. This year’s coverage spans cutting-edge developments, including CAR-T monitoring using AI, gene therapy in primary immunodeficiencies, novel approaches in graft-versus-host disease, advances in multiple myeloma treatment, and emerging therapies for refractory viral infections. Explore the highlights: touchhaematology.com/insight/ebmt-2… @TheEBMT #EBMT2026 #Hematology #Transplantation #CellularTherapy #CART #GeneTherapy #Myeloma

🩸 World Haemophilia Day 2026: Diagnosis – the first step to care On World Hemophilia Day (17 April), the global community comes together to raise awareness of inherited bleeding disorders and the critical importance of timely diagnosis. This year’s theme, “Diagnosis: First step to care,” highlights a persistent global challenge. The World Federation of Hemophilia @wfhemophilia (WFH) estimates that more than three-quarters of people living with hemophilia worldwide remain undiagnosed, with similar gaps affecting other bleeding disorders. Delayed diagnosis can limit access to appropriate treatment, support, and long-term care. We proudly support the WFH campaign, which calls on governments, healthcare providers, and advocates worldwide to take action to close the diagnosis gap. Strengthening diagnostic pathways, improving laboratory capacity, and increasing awareness among healthcare professionals are key steps toward equitable care. 📚 Register here to stay up to date and explore free educational resources: touchhaematology.com/your-free-10-m… #WorldHemophiliaDay #WHD2026 #Haematology #BleedingDisorders #Diagnosis #PatientCare #WeBleedToo #LightItUpRed

📢 EAHAD 2026: Discover the late-breaking advances in haemophilia care The 19th Annual Congress of the European Association for Haemophilia and Allied Disorders highlighted promising developments that could shape the future of care for people living with Haemophilia A. Late-breaking data showcased progress in long-term bleed prevention, flexible paediatric prophylaxis and novel non-factor therapies designed to improve joint health and reduce treatment burden. Read more: touchhaematology.com/insight/eahad-… #EAHAD2026 #Haemophilia #RareDisease #Haematology

✨ Don’t forget to nominate your touchHEMATOLOGY Future Leader 2026! Last year, we recognised Dr Côme Bommier as a Future Leader 2025 for his outstanding contributions to hematology: "Being part of the touchHEMATOLOGY Future Leaders programme is both an honour and a reminder that the future of our field will be built through collaboration, curiosity and a shared commitment to improving patients’ lives." Is there a rising star you think deserves a place on our 2026 list? ✨ Make your nomination today: touchhaematology.com/insight/nomina… 📄Look back at our 2025 list: touchhaematology.com/insight/touchh… #FutureLeaders2026 #Haematology #Hematology #RisingStars #NextGenLeaders #MedicalEducation

Have you listened to our latest #Podcast? ‘Advancing outcomes in CP-CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management’ Listen now: touchpodcast.podbean.com/e/advancing-ou… #Hematology #CML#Leukemia #TKIs #HCPeducation #MedicalEducation

Revisited... Managing PNH now means navigating new evidence, novel agents and complex switching decisions. Are you confident in your current strategy? Join Prof. Fattizzo, Dr Kulasekararaj & Dr Nagalla for expert, evidence-based guidance. Watch the accredited discussion today: touchhaematologyime.org/evolving-parad…

📢 CAR-T Therapy: A New Era for Lymphoma CAR-T cell therapy is rapidly transforming lymphoma care — no longer reserved for later lines, but increasingly used earlier in the treatment pathway for patients with DLBCL and select indolent lymphomas. In this interview, Dr Alexey Danilov shares insights on: 🔹 How CAR-T is reshaping treatment sequencing 🔹 Improved outcomes for patients with high-risk disease 🔹 Emerging CAR-T combination strategies 🔹 The expanding role of bispecific antibodies 🔹 Ongoing challenges in ensuring equitable access Read interview: touchhaematology.com/insight/car-t-… #Lymphoma #CART #Oncology #CancerCare

👩‍⚕️ Nursing in the era of CAR T and AI With over 13 years of experience in paediatric oncology and haematology, Thomas Jezequel reflects on how CAR T-cell therapy and artificial intelligence are transforming the nursing role — from guiding patients through complex treatment pathways to driving innovation in nursing research. 🩸 Explore his inspiring perspective on the future of nursing in oncology and haematology: touchhaematology.com/insight/nursin… #Oncology #Haematology #CARTcellTherapy